Histologic analysis of retinal tissue has been considered the gold standard for characterizing retinal degeneration and assessing the efficacy of potential treatments for AMD and inherited retinal dystrophies in the RCS rat.
8,12,26,43–46 However, histologic processing precludes the ability to perform longitudinal analysis, thus increasing the number of animals required for long-term studies. In addition, artifacts from postmortem processing are unavoidable, including fixation and dehydration, which can alter layer thicknesses and mask features of in vivo disease progression. Noninvasive, high-resolution SD-OCT imaging offers an alternative in vivo approach to obtaining structural measurements of disease progression.
30 Spectral-domain OCT imaging has been validated in multiple mouse (
Rho−/−,
Rpe65−/−,
rd1,
rd10) and rat (Rho P23H) inherited retinal degeneration models.
32–34 These studies have consistently reported that SD-OCT is able to capture morphologic changes during disease progression and that SD-OCT thickness measurements are notably higher, but in strong correlation with anatomic thickness measurements.
32–34 In addition, SD-OCT has been able to image well-characterized phenotypes, as in the complete absence of rod OS in the
Rho−/− mouse,
34 and reveal novel in vivo findings that lead to discoveries about disease progression. For example,
Rpe65−/− mice have less distinct laminar organization, leading to the conclusion that expression of cytoskeletal elements and components of the extracellular matrix may be modified and playing a role in disease progression.
34 In a study that characterized and revealed differences in disease progression between the
rd1 and
rd10 mice, retinal separations, often thought to be an artifact of histologic processing, were observed in the
rd10 mice by SD-OCT, confirming their in vivo existence.
32 Because of these findings, multiple studies now use retinal thickness measurements obtained from SD-OCT images to demonstrate the long-term efficacy of various adeno-associated virus gene therapies for various inherited retinal degeneration mouse models (
rd1,
rd10, P23H Rho
+/−,
Rs1h−/−,
rd12).
35–38 Despite the existing validation of SD-OCT and numerous software programs available for segmentation of the retina,
47–52 ONL counts from H&E-stained retinal sections continue to be the main methodology used to illustrate preservation of photoreceptors after therapeutic interventions in the RCS rat.
43–46 The congruency between histologic analysis and SD-OCT analysis demonstrated in this study suggests that SD-OCT may also be used to quantify the efficacy of various therapies longitudinally.